Drug intelligence / Profile preview

compound lidocaine

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Intravenous, Topical, Transdermal, Infiltration, Intramuscular, Subcutaneous, Intradermal, Epidural, Intrathecal, Oral, Oromucosal, Ophthalmic, Rectal, Intranasal
01

Overview

Compound lidocaine refers to a pharmaceutical preparation containing lidocaine as the primary active ingredient, often in combination with other agents for enhanced therapeutic effect. Lidocaine is an amide-type local anesthetic and class Ib antiarrhythmic agent. Its principal mechanism of action is the reversible blockade of voltage-gated sodium channels (primarily on neuronal cell membranes), which inhibits nerve impulse conduction and results in localized numbness or anesthesia[1][5]. In cardiac tissue, it suppresses automaticity by increasing the electrical stimulation threshold of ventricular myocytes during diastole, making it effective for treating ventricular arrhythmias[3][6]. Compound formulations may be used topically (creams, gels, ointments) or via injection for local anesthesia or pain relief in various medical procedures[2][8]. The specific composition and indications depend on the additional components included with lidocaine.

Other names
compound lidocaine
02

Targets

SCN9A (Sodium channel protein type 9 subunit alpha)SCN5A (Sodium channel protein type 5 subunit alpha)SCN10A (Sodium channel protein type X alpha subunit)

Beyond the preview

Go deeper on compound lidocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on compound lidocaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call